Matthew P. Del Giudice's most recent trade in Mira Pharmaceuticals Inc was a trade of 50,000 Stock Options (right to buy) done . Disclosure was reported to the exchange on June 12, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Mira Pharma Inc | Matthew Paul Del Giudice | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2026 | 50,000 | 50,000 | - | - | Stock Options (right to buy) | |
| Telomir Pharma Inc | Matthew Paul Del Giudice | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 May 2026 | 25,000 | 0 | - | - | Incentive Stock Options (right to buy) | |
| Telomir Pharma Inc | Matthew Paul Del Giudice | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2026 | 25,000 | 25,000 | - | - | Incentive Stock Options (right to buy) | |
| Mira Pharma Inc | Matthew Paul Del Giudice | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2024 | 25,000 | 75,000 | - | - | Stock Options (right to buy) | |
| Telomir Pharma Inc | Matthew Paul Del Giudice | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Aug 2024 | 25,000 | 25,000 | - | - | Incentive Stock Options (right to buy) | |
| Mira Pharma Inc | Matthew P. Del Giudice | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2024 | 50,000 | 25,000 | - | - | Nonqualified Stock Option (right to buy) |